Globicatella sanguinis is an unusual pathogen causing bacteremia, meningitis, and urinary tract infection, and can be misidentified as Streptococcus pneumoniae or viridans streptococci due to its colonial morphology. A 76-year-old female patient with hypertension and degenerative arthritis was admitted to the hospital complaining of knee joint pain. Blood culture revealed the presence of Gram-positive cocci, and the isolated organism was equally identified as S. pneumoniae using the MicroScan identification system (Beckman Coulter, USA) and Vitek 2 identification system (bioMérieux, USA). However, the isolate showed optochin resistance based on the optochin disk susceptibility test. The organism was finally confirmed to be G. sanguinis based on 16S rRNA sequencing and hydrogen sulfide production testing. Accurate identification of G. sanguinis isolated from aseptic body fluids including blood is important for appropriate antibiotic selection based on accurate application of interpretative criteria of antimicrobial susceptibility test. (Ann Clin Microbiol 2018;21:40-44)
INTRODUCTION

Globicatella sanguinis was described in 1992 as a new genus
and species when several isolates with phenotypically resemblance to Streptococcus uberis were characterized by Collins et al. [1] . Globicatella strains showed a negative leucine aminopeptidase (LAP) reaction and growth in the presence of 6.5% NaCl, totally opposite phenotypes of viridans streptococci [2, 3] .
Subsequently, a new species of the genus, Globicatella sulfidifaciens, was described, when several animal isolates from Belgium with resemblance to G. sanguinis were studied [4] .
Although there was 99.2% similarity in 16S rRNA of G. sulfidifaciens to those of G. sanguinis, G. sulfidifaciens were classified as a new species based on differences in their whole cell protein patterns and biochemical profiles [4] . Until now, only 43 G. sanguinis isolates from clinical specimens and 14 case reports about bacteremia, meningitis or urinary tract infection have been reported [5] . To best of our knowledge, this is the second report of G. sanguinis bacteremia case identified by 16S rRNA gene sequencing and biochemical test in Korea [6] .
CASE REPORT
A 76-year-old woman visited to the orthopedic surgery department complaining of left knee joint pain. The patient had 2-year history of hypertension and 10-year history of rheumatoid arthritis, but did not take the medication regularly. The pain of left knee joint began to develop 10 years ago and the pain has become worse. The cause of the pain was due to the fluid retention in the joints, and the patient underwent continuous joint aspiration. Her knee pain did not improve with several procedures, so she was admitted to the hospital for the definite diagnosis. The patient was diagnosed with degenerative arthritis and admitted on October 17, 2017. On the day after admission, total left knee replacement was performed with elective surgery.
On the 4 th day after admission, deep wound aspirations were inoculated but there were no microorganisms. Until the 14 th day of hospitalization, surgical site pain persisted and C-reactive protein and erythrocyte sedimentation rate were elevated to 7.70 mg/dL and 96 mm/h, respectively. Surgical site infection was diagnosed by reoperation. Flomoxef, an antibiotic used to pre- ezbiocloud.net) (Fig. 1) . For differential identification to Globicatella species level, the isolate was inoculated on triple sugar iron (TSI) agar and incubated at 35°C ambient air for 2 days.
Since G. sulfidifaciens produce hydrogen sulfide when grown in TSI agar, the medium turns black when this bacterium grows [4] . Moreover, Globicatella shows various biochemical reactions depending on strain [9] and Globicatella may not be included on the database of the commercial identification system [5] . As a result, the bacterium may be overlooked when isolated, reported as unidentified Streptococcus-like organisms, or misidentified as another species. Miller et al. [10] reported two cases of G. sanguinis infection and they used matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS).
Identification scores were 2.26 and 2.22 respectively, which were high confidence identification. If our identification procedure contained MALDI-TOF MS, the blood culture report was finished early.
Our isolate was initially identified as S. pneumoniae by two commercial identification systems in spite of G. sanguinis and G. sulfidifaciens were included in VITEK 2 (bioMérieux) database. Lau et al. [9] reported that two isolates of Globicatella were optochin susceptible. However, Jain et al. [11] reported optochin resistance G. sanguinis. These reports suggested that G. sanguinis showed variable characteristics about optochin resistance. But in our case, there was discrepancy between opto-chin disk susceptibility test and identification of commercial kit.
There were no reports that the antibiotics susceptibility test of Globicatella were influenced by contents of blood agar or lysed horse blood media. More researches need to clear about uncertainty on antibiotics susceptibility of Globicatella.
Since there is no Clinical and Laboratory Standards Institute (CLSI) approval interpretation guideline for Globicatella, it is recommended that the laboratory should report MICs only [10] .
However, in the case reports of several Globicatella infections, results about antibiotic susceptibility were judged by the criteria of viridans group Streptococcus spp. [2, 10, 12, 13] . By the Shewmaker et al. [2] 's report in antibiotic susceptibility of G.
sanguinis, resistance rates to cefuroxime, cefotaxime, and meropenem were high as 74%, 48%, and 37%, respectively, in contrast to 100% susceptibilities to penicillin and amoxicillin.
While using β-lactam-based antibiotic and macrolide as empirical regimen which was related to lowering mortality of bacteremic pneumococcal pneumonia, G. sanguinis had high resistance to both antibiotics [2, 14] . Fluoroquinolone, which was recommended to treat pneumococcal infection, could be an option because G. sanguinis was susceptible to levofloxacin [2, 15] . As our G. sanguinis was fortunately susceptible to cerotaxime, ceftriaxone, meropenem, erythromycin, and levofloxacin, the patient was rapidly recovered from bloodstream infection. While it has been still hard to choose antibiotics, the correct identification of Globicatella was the first important step of the treatment.
While reporting of G. sanguinis infection was rare, the bacteria were related to severe infection such as meningitis, endocarditis, and osteomyelitis. It is difficult to explain that most cases of G. sanguinis infection, including this case, were revealed from aged female patients [5, 9, 10, 12, 13] . G. sanguinis would infect stockbreeding animals and farmer but actual pathway of infection was unknown [9, 12] . In usual, G. sanguinis had high MIC level against 3 rd generation cephalosporin, which was used popularly as empirical antibiotics, but low MIC level against penicillin [2, 12] . Therefore, rapid and correct identification are necessary to treat G. sanguinis infection.
=국문초록=
한국인에서 발생한 Globicatella sanguinis 균혈증 1예 
